Skip to search formSkip to main contentSkip to account menu

Action Code - No change

Known as: No change 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
ObjectiveThe purpose of this study was to evaluate the efficacy and safety of gemcitabine (GEM) and carboplatin (CBP) used as… 
2004
2004
SummaryThirty-five evaluable patients with histologically confirmed primary liver cancer (PLC) were treated with m-AMSA. All… 
1995
1995
Results with second-line treatment of advanced colorectal cancer are poor. Preliminary phase I/II results suggest encouraging… 
1995
1995
The efficacy of medroxyprogesterone acetate (MPA) therapy in controlling progressive measurable metastatic breast cancer was… 
1992
1992
The combination therapy with natural type human tumor necrosis factor (n-TNF; MHR-24) and human lymphoblastoid interferon-alpha… 
1990
1990
Twenty-three patients with disseminated malignant melanoma were entered in a pilot study conducted from January 1983 to January… 
Review
1990
Review
1990
Since January 1986 in a phase I/II study. 45 lesions (30 head and neek, 11 pelvie, and 4 other lesions) in 44 patients (24 men… 
1987
1987
In a phase-II-trial 40 patients with advanced gastric cancer were treated with 5-fluorouracil, 4-epidoxorubicin, mitomycin C (FEM… 
1987
1987
Analyses of relapse in small cell lung cancer (SCLC) were performed in 443 evaluable patients included in two multicenter trials… 
1983
1983
Patients with unresectable liver cancer (primary and metastatic) were treated with a newly-devised arterial infusion chemotherapy…